Therapeutic Peptides for Treatment of Lung Diseases: Infection, Fibrosis, and Cancer.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Therapeutic Peptides for Treatment of Lung Diseases: Infection, Fibrosis, and Cancer.
- Published In:
- International journal of molecular sciences, 24(10) (2023)
- Authors:
- Li, Shujiao, Li, Yuying, Liu, Ying(3), Wu, Yifan, Wang, Qiuyu, Jin, Lili, Zhang, Dianbao
- Database ID:
- RPEP-07100
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07100APA
Li, Shujiao; Li, Yuying; Liu, Ying; Wu, Yifan; Wang, Qiuyu; Jin, Lili; Zhang, Dianbao. (2023). Therapeutic Peptides for Treatment of Lung Diseases: Infection, Fibrosis, and Cancer.. International journal of molecular sciences, 24(10). https://doi.org/10.3390/ijms24108642
MLA
Li, Shujiao, et al. "Therapeutic Peptides for Treatment of Lung Diseases: Infection, Fibrosis, and Cancer.." International journal of molecular sciences, 2023. https://doi.org/10.3390/ijms24108642
RethinkPeptides
RethinkPeptides Research Database. "Therapeutic Peptides for Treatment of Lung Diseases: Infecti..." RPEP-07100. Retrieved from https://rethinkpeptides.com/research/li-2023-therapeutic-peptides-for-treatment
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.